{
    "root": "34184fdf-e74f-fa7f-e063-6294a90a66c3",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "telmisartan",
    "value": "20250501",
    "ingredients": [
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_29864"
        },
        {
            "name": "MEGLUMINE",
            "code": "6HG8UB2MUY",
            "drugbank_id": "https://go.drugbank.com/drugs/DB09415"
        },
        {
            "name": "POVIDONE",
            "code": "FZ989GH94E",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11061"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        },
        {
            "name": "SODIUM STEARYL FUMARATE",
            "code": "7CV7WJK4UI",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00815"
        },
        {
            "name": "TELMISARTAN",
            "code": "U5SYW473RQ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9434"
        }
    ],
    "indications": {
        "text": "telmisartan tablets , usp angiotensin ii receptor blocker ( arb ) indicated : treatment hypertension , lower blood pressure . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 ) cardiovascular ( cv ) risk reduction patients unable take ace inhibitors ( 1.2 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "may administered without food ( 2.1 ) used cardiovascular risk reduction , monitoring blood pressure recommended , appropriate , adjustment medications lower blood pressure may necessary ( 2.2 ) indication starting dose dose range hypertension ( 2.1 ) 40 mg daily 40 80 mg daily cardiovascular risk reduction ( 2.2 ) 80 mg daily 80 mg daily",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "telmisartan tablets , usp supplied : 20 mg , white off-white uncoated round shaped tablets , flat , beveled edges , plain one side debossed \u201c 036 \u201d side . ndc 72789-371-90 bottle 90 tablets storage store 20 oto 25 oc ( 68 oto 77 ) [ usp controlled room temperature ] . dispense tightly closed container . insert cotton every time back bottle every consumption",
    "adverseReactions": "telmisartan contraindicated patients known hypersensitivity ( e.g . , anaphylaxis angioedema ) telmisartan component product [ ( 6.2 ) ] . co-administer aliskiren telmisartan patients diabetes . [ ( 7 ) ] .",
    "indications_original": "Telmisartan tablets, USP are an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Cardiovascular (CV) risk reduction in patients unable to take ACE inhibitors ( 1.2 )",
    "contraindications_original": "May be administered with or without food ( 2.1 ) When used for cardiovascular risk reduction, monitoring of blood pressure is recommended, and if appropriate, adjustment of medications that lower blood pressure may be necessary ( 2.2 ) Indication Starting Dose Dose Range Hypertension ( 2.1 ) 40 mg once daily 40 to 80 mg once daily Cardiovascular Risk Reduction ( 2.2 ) 80 mg once daily 80 mg once daily",
    "warningsAndPrecautions_original": "Telmisartan Tablets, USP are supplied as below: \n    20 mg, white to off-white uncoated round shaped tablets, flat, with beveled edges, plain on one side and debossed \u201c036\u201don other side. \n    NDC 72789-371-90 bottle of 90 tablets \n  \n                  \n                  \n                     Storage\n                  \n                  \n                     Store at 20\n  \n   oto 25\n  \n   oC (68\n  \n   oto 77\n  \n   oF)\n \n  [see USP Controlled Room Temperature].\n\n \n                  Dispense in a tightly closed container.\n                  Insert the cotton every time back in to the bottle after every consumption",
    "adverseReactions_original": "Telmisartan is contraindicated in patients with known hypersensitivity (e.g., anaphylaxis or angioedema) to telmisartan or any other component of this product\n \n  [see\n  \n   Adverse Reactions (6.2)].\n \n  \n                  \n                  Do not co-administer aliskiren with telmisartan in patients with diabetes.\n \n  [see\n  \n   Drug interactions(7)].",
    "drug": [
        {
            "name": "telmisartan",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9434"
        }
    ]
}